Памревлумаб

Rec. INN (наименование, зарегистрированное ВОЗ)

USAN (наименование, принятое к употреблению в США)

DB14952

946415-13-0

immunoglobulin G1-kappa, anti-[Homo sapiens CTGF (connective tissue growth factor, CCN family member 2, CCN2, hypertrophic chondrocyte-specific protein 24, HCS24, insulin-like growth factor-binding protein 8, IGFBP8)], Homo sapiens monoclonal antibody;
gamma1 heavy chain (1-449) [Homo sapiens VH (IGHV3- 48*03 (84.70%) -(IGHD)-IGHJ4*01) [8.7.14] (1-120) - IGHG1*03, G1m3 (CH1 (121-218), hinge (219-233), CH2 (234-343), CH3 (344-448), CHS K2>del (449)) (121-449)], (223-214')-disulfide with kappa light chain (1'-214') [Homo sapiens V-KAPPA (IGKV1D-16*01 (100.00%) -IGKJ2*01) [6.3.9] (1'-107') -IGKC*01, Km3 (108'-214')]; dimer(229- 229'':232-232'')-bisdisulfide

C₆₄₉₂H₁₀₀₁₈N₁₇₁₈O₂₀₈₆S₄₈

147050,38 г/моль

Поделиться этой страницей